» Articles » PMID: 22270320

Fibroblasts Prepared from Different Types of Malignant Tumors Stimulate Expression of Luminal Marker Keratin 8 in the EM-G3 Breast Cancer Cell Line

Overview
Publisher Springer
Date 2012 Jan 25
PMID 22270320
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

It is widely recognized that stromal fibroblasts significantly influence biological properties of multiple tumors including breast cancer. However, these epithelial-mesenchymal interactions seem to be essential in tumor biology and it is not fully clear whether this interaction is tumor type-specific or has a more general non-specific character. To elucidate this question, we tested the effect of cancer-associated fibroblasts (CAFs) isolated from different types of tumors (breast cancer skin metastasis, cutaneous basal cell carcinoma and melanoma, squamous cell carcinoma arising from oral cavity mucous membrane) on the EM-G3 breast cancer cell line. The results were compared with control experiments using normal human dermal fibroblasts, 3T3 mouse fibroblasts, and 3T3 fibroblasts influenced by the fibroblasts prepared from the basal cell carcinoma. Our results demonstrated that expression of luminal marker keratin 8 was influenced only by CAFs prepared from any tested tumors. In contrast, all tested types of fibroblasts showed a strong stimulatory effect on the expression of basal/myoepithelial marker keratin 14. The CAFs also elevated the number of cells with positivity for both keratins 8 and 14 that are similar to ductal originated precursor cells. The expression of proliferation marker Ki67 was not influenced by any of the tested fibroblasts. In conclusion, our data indicate that CAFs are able to influence the phenotype of a breast cancer cell line and this effect is based on a tumor type-unspecific mechanism. Finally, a clear functional difference between normal and CAFs was demonstrated.

Citing Articles

The HOX code of human adult fibroblasts reflects their ectomesenchymal or mesodermal origin.

Pfeiferova L, Spanko M, Sachova J, Hradilova M, Pienta K, Valach J Histochem Cell Biol. 2025; 163(1):38.

PMID: 40063181 PMC: 11893657. DOI: 10.1007/s00418-025-02362-9.


Unravelling heterogeneous effects of cancer‑associated fibroblasts on poor prognosis markers in breast cancer EM‑G3 cell line: ‑targeted treatment (anti‑IL-6, anti‑VEGF-A, anti‑MFGE8) based on transcriptomic profiling.

Urban L, Novak S, Coma M, Dvorankova B, Lacina L, Sachova J Oncol Rep. 2023; 51(1).

PMID: 37975220 PMC: 10688412. DOI: 10.3892/or.2023.8662.


Heterogeneous response to TGF-β1/3 isoforms in fibroblasts of different origins: implications for wound healing and tumorigenesis.

Urban L, Coma M, Lacina L, Szabo P, Sabova J, Urban T Histochem Cell Biol. 2023; 160(6):541-554.

PMID: 37707642 PMC: 10700238. DOI: 10.1007/s00418-023-02221-5.


"In the light of evolution:" keratins as exceptional tumor biomarkers.

Takan I, Karakulah G, Louka A, Pavlopoulou A PeerJ. 2023; 11:e15099.

PMID: 36949761 PMC: 10026720. DOI: 10.7717/peerj.15099.


Expression of Selected miRNAs in Normal and Cancer-Associated Fibroblasts and in BxPc3 and MIA PaCa-2 Cell Lines of Pancreatic Ductal Adenocarcinoma.

Mandys V, Popov A, Gurlich R, Havranek J, Pfeiferova L, Kolar M Int J Mol Sci. 2023; 24(4).

PMID: 36835029 PMC: 9961675. DOI: 10.3390/ijms24043617.


References
1.
Haviv I, Polyak K, Qiu W, Hu M, Campbell I . Origin of carcinoma associated fibroblasts. Cell Cycle. 2009; 8(4):589-95. DOI: 10.4161/cc.8.4.7669. View

2.
de Wever O, Demetter P, Mareel M, Bracke M . Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer. 2008; 123(10):2229-38. DOI: 10.1002/ijc.23925. View

3.
Strnad H, Lacina L, Kolar M, cada Z, Vlcek C, Dvorankova B . Head and neck squamous cancer stromal fibroblasts produce growth factors influencing phenotype of normal human keratinocytes. Histochem Cell Biol. 2009; 133(2):201-11. DOI: 10.1007/s00418-009-0661-6. View

4.
Abd El-Rehim D, Pinder S, Paish C, Bell J, Blamey R, Robertson J . Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol. 2004; 203(2):661-71. DOI: 10.1002/path.1559. View

5.
Clarke C, Sandle J, Lakhani S . Myoepithelial cells: pathology, cell separation and markers of myoepithelial differentiation. J Mammary Gland Biol Neoplasia. 2006; 10(3):273-80. DOI: 10.1007/s10911-005-9587-3. View